BIOEXTRAX AB (F:85X0) — Stock Price

€0.20 EUR
▲ 2.28% today

BIOEXTRAX AB (F:85X0) is currently trading at €0.20 EUR, up 2.28% today. Over the past 52 weeks, shares have ranged between €0.16 and €0.34. This page tracks BIOEXTRAX AB's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see BIOEXTRAX AB operating cash flow efficiency.

BIOEXTRAX AB (85X0) Stock Price Chart — Daily History & Trading Volume

The chart below tracks BIOEXTRAX AB's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

BIOEXTRAX AB Income Statement — Revenue, Profit & Earnings by Year

BIOEXTRAX AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €757.00K €515.00K €2.06 Million €395.00K €276.00K
Cost of Revenue €1.26 Million €1.43 Million €1.34 Million €1.34 Million €1.03 Million
Gross Profit €-501.00K €-915.00K €718.00K €-950.00K €-757.00K
Research & Development — — — — —
SG&A — — — €9.16 Million €3.39 Million
Total Operating Expenses €18.60 Million €18.05 Million €23.66 Million €19.06 Million €10.80 Million
Operating Income €-17.84 Million €-17.54 Million €-21.60 Million €-18.67 Million €-10.53 Million
EBITDA — — — — —
EBIT — — — — —
Interest Expense €1.00K €2.00K €0.00 €0.00 €3.00K
Income Before Tax €-17.70 Million €-17.34 Million €-21.51 Million €-18.67 Million €-10.53 Million
Income Tax Expense — — — — —
Net Income €-17.70 Million €-17.34 Million €-21.51 Million €-18.67 Million €-10.53 Million

BIOEXTRAX AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes BIOEXTRAX AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €24.73 Million €29.00 Million €22.52 Million €37.92 Million €12.64 Million
Total Current Assets €5.54 Million €19.20 Million €14.76 Million €30.40 Million €11.42 Million
Cash & Equivalents — — — — —
Short-term Investments — — — — —
Net Receivables €28.00K €0.00 €0.00 €33.00K €119.00K
Inventory — — — — —
Property, Plant & Equipment — — — — —
Goodwill — — — — —
Total Liabilities €3.51 Million €2.94 Million €1.98 Million €6.15 Million €5.14 Million
Total Current Liabilities €3.51 Million €2.94 Million €1.98 Million €6.15 Million €5.14 Million
Long-term Debt — — — — —
Net Debt — — — — —
Total Stockholder Equity €21.21 Million €26.06 Million €20.54 Million €31.77 Million €7.50 Million
Retained Earnings €6.68 Million €1.73 Million €9.21 Million €-11.24 Million €-9.20 Million

BIOEXTRAX AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how BIOEXTRAX AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €-26.05 Million €-18.78 Million €-23.31 Million €-17.60 Million €-8.48 Million
Capital Expenditures €152.00K €215.00K €1.10 Million €6.78 Million €975.00K
Free Cash Flow €-26.20 Million €-18.99 Million €-24.41 Million €-24.38 Million €-9.45 Million
Investing Cash Flow — — — — —
Financing Cash Flow — — — — —
Dividends Paid — — — — —
Stock-Based Compensation — — — — —
Depreciation €1.13 Million €1.16 Million €861.00K €477.00K €350.00K
Change in Cash €-13.34 Million €3.87 Million €-14.13 Million €18.55 Million €6.92 Million

BIOEXTRAX AB Earnings History — EPS Actual vs. Analyst Estimates

Track BIOEXTRAX AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Earnings history is not currently available for BIOEXTRAX AB.